Thank you for donating!
You can donate using the following services.
Donate Today
Search
Need support today?
Email: info@npuk.org
Helpline: 0191 415 0693
Main menu
Niemann-Pick Diseases
About Us
Care & Support
Research
Fundraising
Resources
Blog
News
NPUK Shop
COVID-19
News
NPUK
>
News
28.06.22
Press Release: Xenpozyme® (olipudase alfa) approved by European Commission as first and only treatment for ASMD
Read more
15.06.22
IntraBio: IB1001-301 (UK Recruitment)
Read more
30.05.22
Mandos NPC1 Community Newsletter, May 2022
Read more
24.05.22
TransportNPC: Scott Fine, CEO of Cyclo Therapeutics
Read more
20.05.22
CHMP recommends approval of Xenpozyme® (olipudase alfa), the first and only treatment for ASMD
Read more
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
Next
Clinical Trials
CTD Holdings Inc
IntraBio
News
NPUK Annual Family Conference
NPUK News
Orphazyme
Sanofi Genzyme
The Quinn Madeline Foundation
Uncategorized
Donate today
Follow NPUK
Contact us
Donate today
Email: info@npuk.org
Helpline: 0191 415 0693